Concord Wealth Partners Acquires 4,684 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Concord Wealth Partners boosted its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 34.3% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 18,355 shares of the biopharmaceutical company’s stock after purchasing an additional 4,684 shares during the period. Concord Wealth Partners’ holdings in Gilead […]

Related Keywords

United States ,Merdad Parsey ,Complera Eviplera ,Gilead Sciences Price Performance ,Gilead Sciences ,Etesian Wealth Advisors Inc ,Institutional Family Asset Management ,Gilead Sciences Inc ,Nasdaq ,News Ratings For Gilead Sciences Daily ,Insider Transactions At Gilead Sciences ,Nilsine Partners ,Morgan Stanley ,Maxim Group ,Financial Counselors Inc ,Gilead Sciences Dividend Announcement ,Wealth Partners ,Quarter For Gilead Sciences ,Concord Wealth Partners ,Free Report ,Wealth Partner ,Wealth Advisors ,Family Asset Management ,Truist Financial ,Get Free Report ,Visit Holdingschannel ,Gilead Sciences Daily ,Nasdaq Gild ,Gild ,Medical ,37555810 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,